[
    [
        {
            "time": "2023-10-18",
            "original_text": "Medical stocks on the move: AbbVie, Arrowhead Pharmaceuticals and Zynex",
            "features": {
                "keywords": [
                    "Medical stocks",
                    "AbbVie",
                    "Arrowhead Pharmaceuticals",
                    "Zynex"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "Medical stocks on the move: AbbVie, Arrowhead Pharmaceuticals and Zynex",
                "Correlation": 9,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 7,
                "Duration": 5,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "5 Excellent GARP Picks Based on Discounted PEG",
            "features": {
                "keywords": [
                    "GARP",
                    "Discounted PEG"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "neutral"
            },
            "scores": {
                "News_content": "5 Excellent GARP Picks Based on Discounted PEG",
                "Correlation": 5,
                "Sentiment": 6,
                "Importance": 5,
                "Impact": 4,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "2023-10-18",
            "original_text": "The Zacks Analyst Blog Highlights: Cintas, Air Products, Walmart, Target and AbbVie",
            "features": {
                "keywords": [
                    "Zacks Analyst Blog",
                    "Cintas",
                    "Air Products",
                    "Walmart",
                    "Target",
                    "AbbVie"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "retail",
                    "industrial goods",
                    "healthcare"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "The Zacks Analyst Blog Highlights: Cintas, Air Products, Walmart, Target and AbbVie",
                "Correlation": 8,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]